Aplagon secures EUR 7 million for APAC phase 2a trials
3rd February 2025 Uncategorised 0
Funding led by new investors FSG and EIC Fund
More: Aplagon secures EUR 7 million for APAC phase 2a trials
Source: News
Funding led by new investors FSG and EIC Fund
More: Aplagon secures EUR 7 million for APAC phase 2a trials
Source: News
© 1994 - 2025 B.M. Pharmaceuticals